Sildenafil Citrate Powder, For Suspension
Product Images NDC 72205-059

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 72205-059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sild-susp-structure (Sild Susp Structure)

Chemical structure of sildenafil citrate, showing the molecular arrangement of the active ingredient sildenafil along with its citrate component.*

FDA Label Image

Sild-susp-fig-01 (Sild Susp Fig 01)

A chart showing fold changes and 90% confidence intervals in AUC and Cmax for various drugs when administered with sildenafil citrate. The x-axis depicts change relative to sildenafil alone, with a vertical line at 1. Drugs analyzed include atorvastatin, azithromycin, bosentan, cimetidine, erythromycin, Maalox, oral contraceptives, ritonavir, and saquinavir. Recommendations vary between no dose adjustment and coadministration not recommended.*

FDA Label Image

Sild-susp-fig-02 (Sild Susp Fig 02)

A chart showing fold change and 90% confidence intervals for various pharmacokinetic parameters (INR, AUC, Cmax, and bleeding time) when sildenafil citrate is coadministered with different interacting drugs. The chart includes recommendations for dose adjustment, mostly indicating no dose adjustment or advising against coadministration for specific drugs.*

FDA Label Image

Sild-susp-fig-03 (Sild Susp Fig 03)

A line graph showing the change from baseline in a measured variable over weeks 4, 8, and 12 of a study. The graph compares results for four groups identified by different markers: sildenafil 40 mg three times daily, sildenafil 80 mg three times daily, placebo, and another sildenafil 80 mg three times daily group. Values are displayed with error bars indicating variability.*

FDA Label Image

Sild-susp-fig-04 (Sild Susp Fig 04)

A horizontal dot plot comparing the placebo-corrected change in 6-minute walk distance (m) for sildenafil 20 mg TID versus placebo, stratified by factors such as baseline walk distance, etiology (idiopathic PAH, PAH-CTD, PAH-surgical repair), PAH criteria for functional capacity, gender, age, mean PAH reading, and PYRL dyspnea scores. Each subgroup shows mean values with confidence intervals.*

FDA Label Image

Sild-susp-fig-05 (Sild Susp Fig 05)

A survival curve chart comparing the percentage of patients without a clinically worsening event over days from randomization between placebo and sildenafil citrate groups. The x-axis represents days, and the y-axis shows the percentage without worsening, with sildenafil showing a higher percentage than placebo over the 112-day period.*

FDA Label Image

Sild-susp-fig-a (Sild Susp Fig A)

Illustration showing components of sildenafil citrate powder for oral suspension product, including bottle with cap and adaptor, and an oral dosing syringe with labeled parts: tip, barrel with volume markings, and plunger.*

FDA Label Image

Sild-susp-fig-b (Sild Susp Fig B)

An instructional illustration showing how to shake a bottle of sildenafil citrate powder for suspension by moving it up and down and rotating it, alongside a stopwatch indicating timing for the process.*

FDA Label Image

Sild-susp-fig-c (Sild Susp Fig C)

An instructional diagram labeled Figure C showing a hand pressing down and twisting the cap of a bottle, demonstrating how to open or secure the bottle. The bottle is cylindrical with an arrow indicating the direction of twist.*

FDA Label Image

Sild-susp-fig-d (Sild Susp Fig D)

Illustration showing proper technique for inserting a dropper into a bottle, with a finger pressing down on the top of the dropper. The inset details the finger pressing down on the dropper top, indicating how to use the dropper for dispensing the medication.*

FDA Label Image

Sild-susp-fig-e (Sild Susp Fig E)

An instructional illustration showing a hand holding an upright bottle with a liquid being dispensed into a syringe held below it. The image demonstrates the method for drawing liquid medication from a suspension bottle using a syringe, labeled as Figure E.*

FDA Label Image

Sild-susp-fig-f (Sild Susp Fig F)

An instructional illustration showing a hand holding a bottle and another hand pulling up on a syringe inserted into the bottle's neck, labeled as Figure F. The image depicts the process of drawing liquid from a bottle using a syringe, relevant to the oral suspension dosage form of sildenafil citrate powder for suspension.*

FDA Label Image

Sild-susp-fig-g (Sild Susp Fig G)

An illustration showing an adult person taking an oral dose using a syringe, with an arrow indicating the direction of administration into the mouth. The figure is labeled 'Figure G'.*

FDA Label Image

Sild-susp-fig-h (Sild Susp Fig H)

An instructional illustration labeled Figure H showing a hand gripping and twisting the cap of a bottle, with arrows indicating the directions to twist for opening or closing. The bottle appears to be a container for oral suspension medication.*

FDA Label Image

Sild-susp-fig-i (Sild Susp Fig I)

An instructional line drawing labeled Figure I, showing a water faucet above a syringe and a vial, likely illustrating how to prepare or administer a medication for oral suspension.*

FDA Label Image

Sild-susp-carton-label (Sild Susp Carton Label)

Label for sildenafil oral suspension 10 mg/mL powder for suspension, grape flavored, in a 112 mL bottle. The label includes directions for reconstitution, recommended storage before and after reconstitution, and manufacturer information for MSN Pharmaceuticals Inc, with distribution by Novadoz Pharmaceuticals LLC. The label also features instructions to shake well before use and a barcode.*

FDA Label Image

Sild-susp-bottle-label (Sild Susp Bottle Label)

Label for sildenafil citrate oral suspension 10 mg/mL by Novadoz Pharmaceuticals LLC. The powder for suspension is grape flavored and intended for oral use. It includes storage instructions before and after reconstitution, dosage information, and a barcode. The label shows the product NDC 72205-059-76 and contact details for Novadoz Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.